ClinicalTrials.Veeva

Menu

Short-term Automated Longitudinal Analysis of Speech and Language in Cognitive Impairment

A

Accexible

Status

Unknown

Conditions

Mild Cognitive Impairment
Dementia

Treatments

Other: Speech analysis

Study type

Interventional

Funder types

Industry

Identifiers

NCT05340218
18/475-E

Details and patient eligibility

About

Validate speech analysis AI models:

  • To contrast the accuracy of acceXible's platform as a screening tool in the detection of people with cognitive impairment and mild dementia.
  • To evaluate the correlation between automatically analyzed linguistic variables and a combination of standard measures of cognition.
  • To assess short-term variability in language ability among older adults, and to assess which aspects of language vary during the study period.

Enrollment

300 estimated patients

Sex

All

Ages

55 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adult patients 55+ years of age with suspected MCI or diagnosis of dementia and obtains a score greater than 20 on the MMSE.
  • Patients must have agreed to participate in the study and have voluntarily signed the informed consent.
  • (Healthy) Participants without a diagnosis neurological, or psychiatric disorders. Or taking medication that can affect cognitive abilities.

Exclusion Criteria

  • To have received a diagnosis of a significant psychiatric disorder or other cognitive impairment not due to neurodegeneration.
  • To have significant vision problems that would affect the ability to perceive visual stimuli.
  • To have significant hearing problems that would affect the ability to understand verbal cues.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems